Related Experiment Videos
Bisphosphonate-induced osteopetrosis
Michael P Whyte1, Deborah Wenkert, Karen L Clements
1Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children, St. Louis, MO 63131-3597, USA. mwhyte@shrinenet.org
The New England Journal of Medicine
|August 2, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477].
Bone·2025
Same author
Duplications within exon 1 of TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK) are associated with tendon avulsion.
Bone·2025
Same author
Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631).
Bone·2025
Same author
Transmembrane protein 53 craniotubular dysplasia (OMIM # 619727): The skeletal disease and consequent blindness of this new disorder.
Bone·2024
Same author
Pediatric hypophosphatasia: avoid diagnosis missteps!
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2024
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
The New England journal of medicine·2026
Same journal
Hypertension Control in Low-Income Patients. Reply.
The New England journal of medicine·2026